findmyKOL

Fabio Danisi, MD

Basic profile

Westchester Medical Center

ORCIDNPI
RegionKingston, NY · NortheastSpecialtyNeurologyFocusNeurology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Fabio Danisi is a Neurology physician affiliated with Westchester Medical Center. OpenAlex indexes 26 publications with 851 citations (h-index 13).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
26publications

Distinct works indexed by OpenAlex, matched via ORCID.

851citations

Total citations across indexed works.

13h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
19companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

365 Broadway
Kingston, NY 124015151

Telephone

845-331-5165

Provider last certified this registry record 29 Nov 2021.

View the NPPES registry record

Industry payments

19 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Musculoskeletal

    86.8%
    Neuromuscular Blocker86.5%
    Onabotulinumtoxina51%Incobotulinumtoxin a50%
    Part B, office-administered25 patients
    gamma-Aminobutyric Acid-ergic Agonist0.3%
    Baclofen100%
    Part D13 patients

    + 1 more class in this area

  • Nervous system

    12.2%
    Aromatic Amino Acid Decarboxylation Inhibitor5%
    Carbidopa-Levodopa51%Carbidopa-Levodopa Er36%Rytary10%Carbidopa2%Carbidopa-Levodopa-Entacapone1%
    Part D<11 patients
    Nonergot Dopamine Agonist1%
    Pramipexole Dihydrochloride60%Ropinirole Hcl25%Ropinirole Er8%Neupro7%
    Part D<11 patients

    + 23 more classes in this area

  • Cardiovascular

    0.7%
    Beta blocker0.4%
    Propranolol Hcl Er55%Propranolol Hcl45%
    Part D<11 patients
    ACE inhibitor0.2%
    Benazepril Hcl55%Captopril45%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)0.3% facility · 99.7% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”